Latham & Watkins LLP represented the underwriters in the transaction. Alphamab Oncology raised approximately HK$1.83 billion (US$234 million) in its Hong Kong initial public offering. The…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
